The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni

Schistosomiasis mansoni is a poverty-related parasitic infection that has a variety of clinical manifestations. We consider the disability and deaths caused by schistosomiasis unacceptable for a tool-ready disease. Its condition in Brazil warrants an analysis that will enable better understanding of...

Full description

Saved in:
Bibliographic Details
Published in:Memórias do Instituto Oswaldo Cruz 2019-01, Vol.114, p.e180347-e180347
Main Authors: Nascimento, Gilmara Lima, Pegado, Helio Milani, Domingues, Ana Lúcia Coutinho, Ximenes, Ricardo Arraes de Alencar, Itria, Alexander, Cruz, Luciane Nascimento, Oliveira, Maria Regina Fernandes de
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Brazil - epidemiology
Carrier State - economics
Carrier State - parasitology
Child
Child, Preschool
cost of illness
Health Care Costs - statistics & numerical data
Humans
Infant
Infant, Newborn
Middle Aged
Original
PARASITOLOGY
Prevalence
schistosomiasis mansoni
Schistosomiasis mansoni - economics
Schistosomiasis mansoni - epidemiology
TROPICAL MEDICINE
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Schistosomiasis mansoni is a poverty-related parasitic infection that has a variety of clinical manifestations. We consider the disability and deaths caused by schistosomiasis unacceptable for a tool-ready disease. Its condition in Brazil warrants an analysis that will enable better understanding of the local health losses and contribute to the complex decision-making process. This study estimates the cost of schistosomiasis in Brazil in 2015. We conducted a cost of illness study of schistosomiasis mansoni in Brazil in 2015 based on a prevalence approach and from a societal perspective. The study included 26,499 schistosomiasis carriers, 397 hepatosplenic cases, 48 cases with the neurological form, 284 hospitalisations, and 11,368.26 years of life lost (YLL) of which 5,187 years are attributable to economically active age groups. The total cost of schistosomiasis mansoni in Brazil was estimated to be US$ 41,7million in 2015 with 94.61% of this being indirect costs. The economic burden of schistosomiasis mansoni in Brazil is high and results in the loss of productivity. Its persistence in Brazil is a challenge to public health and requires inter-sectorial interventions in areas such as indoor water supply, basic sanitation, and education.
ISSN:0074-0276
1678-8060
1678-8060
DOI:10.1590/0074-02760180347